UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis

Clinical infectious diseases, 2019-04, Vol.68 (8), p.1351-1358

2019

Volltextzugriff (PDF)

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1613-e1620

2021

Volltextzugriff (PDF)

Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection

Clinical infectious diseases, 2021-10, Vol.73 (7), p.e1706-e1712

2021

Volltextzugriff (PDF)

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

Inflammatory bowel diseases, 2007-02, Vol.13 (2), p.175-181

2007

Volltextzugriff (PDF)

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency

Clinical infectious diseases, 2017-11, Vol.65 (10), p.1745-1747

2017

Volltextzugriff (PDF)

In Search of the (Clostridium difficile) Holy Grail

Clinical infectious diseases, 2020-03, Vol.70 (6), p.1094-1095

2020

Volltextzugriff (PDF)

Reply to Lagier et al

Clinical infectious diseases, 2020-05, Vol.70 (11), p.2454-2455

2020

Volltextzugriff (PDF)

Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis

Inflammatory bowel diseases, 2024-07, Vol.30 (7), p.1178-1188

2024

Volltextzugriff (PDF)

Reply to Khoruts and Sadowsky

Clinical infectious diseases, 2019-11, Vol.69 (12), p.2233-2234

2019

Volltextzugriff (PDF)

Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study

Clinical infectious diseases, 2016-03, Vol.62 (5), p.596-602

2016

Volltextzugriff (PDF)

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

The Journal of infectious diseases, 2016-07, Vol.214 (2), p.173-181

2016

Volltextzugriff (PDF)

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

Clinical infectious diseases, 2021-06, Vol.72 (12), p.2132-2140

2021

Volltextzugriff (PDF)

Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection

Inflammatory bowel diseases, 2019-02, Vol.25 (3), p.610-619

2019

Volltextzugriff (PDF)

Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis

Clinical infectious diseases, 2018-02, Vol.66 (4), p.514-522

2018

Volltextzugriff (PDF)

The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study

Clinical infectious diseases, 2013-05, Vol.56 (10), p.1401-1406

2013

Volltextzugriff (PDF)

Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease

Inflammatory bowel diseases, 2020-09, Vol.26 (9), p.1415-1420

2020

Volltextzugriff (PDF)

Clinical guidelines for the management of pouchitis

Inflammatory bowel diseases, 2009-09, Vol.15 (9), p.1424-1431

2009

Volltextzugriff (PDF)

Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis

Inflammatory bowel diseases, 2013-07, Vol.19 (8), p.1631-1638

2013

Volltextzugriff (PDF)

"Community-Acquired Clostridium difficile Infection: An Emerging Entity"

Clinical infectious diseases, 2012-12, Vol.55 (12), p.1741-1742

2012

Volltextzugriff (PDF)

Management of the elderly patients with inflammatory bowel disease: practical considerations

Inflammatory bowel diseases, 2013-09, Vol.19 (10), p.2257-2272

2013

Volltextzugriff (PDF)

Reply to Davido et al

Clinical infectious diseases, 2018-01, Vol.66 (3), p.483-485

2018

Volltextzugriff (PDF)

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy

Inflammatory bowel diseases, 2021-04, Vol.27 (5), p.594-602

2021

Volltextzugriff (PDF)

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

Inflammatory bowel diseases, 2018-06, Vol.24 (7), p.1582-1588

2018

Volltextzugriff (PDF)

Microscopic Colitis. An update

Inflammatory bowel diseases, 2004-11, Vol.10 (6), p.860-870

Pardi, Darrell S.

2004

Volltextzugriff (PDF)

Open‐label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

Inflammatory bowel diseases, 2009-09, Vol.15 (9), p.1302-1307

2009

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

KollektionOxford Journals 2020 Medicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(51)
Mit Volltextzugriff
(51)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Menü

Weitere Dienste

Einstellungen

Low Cure Rates in Controlled Trials of Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection: A Systematic Review and Meta-analysis

RBX7455, a Non-frozen, Orally Administered Investigational Live Biotherapeutic, Is Safe, Effective, and Shifts Patients’ Microbiomes in a Phase 1 Study for Recurrent Clostridioides difficile Infections

Durability of Response to Fecal Microbiota Transplantation After Exposure to Risk Factors for Recurrence in Patients With Clostridioides difficile Infection

Symptomatic overlap between irritable bowel syndrome and microscopic colitis

Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency

In Search of the (Clostridium difficile) Holy Grail

Reply to Lagier et al

Effectiveness and Safety Profile of Budesonide Maintenance in Microscopic Colitis: A Systematic Review and Meta-Analysis

Reply to Khoruts and Sadowsky

Safety and Durability of RBX2660 (Microbiota Suspension) for Recurrent Clostridium difficile Infection: Results of the PUNCH CD Study

A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection

SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial

Colon Surgery Risk With Corticosteroids Versus Immunomodulators or Biologics in Inflammatory Bowel Disease Patients With Clostridium difficile Infection

Low Risk of Primary Clostridium difficile Infection With Tetracyclines: A Systematic Review and Metaanalysis

The Epidemiology of Clostridium difficile Infection in Children: A Population-Based Study

Efficacy of Fecal Microbiota Transplantation for Recurrent C. Difficile Infection in Inflammatory Bowel Disease

Clinical guidelines for the management of pouchitis

Effect of ursodeoxycholic acid use on the risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a systematic review and meta-analysis

"Community-Acquired Clostridium difficile Infection: An Emerging Entity"

Management of the elderly patients with inflammatory bowel disease: practical considerations

Reply to Davido et al

A 1-Year Cross-sectional Inflammatory Bowel Disease Surveillance Colonoscopy Cohort Comparing High-definition White Light Endoscopy and Chromoendoscopy

Clinical Benefit of Capsule Endoscopy in Crohn's Disease: Impact on Patient Management and Prevalence of Proximal Small Bowel Involvement

Microscopic Colitis. An update

Open‐label study of adalimumab in patients with ulcerative colitis including those with prior loss of response or intolerance to infliximab

Aktive Filter

Suchergebnisse filtern